NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1799133714|ref|NP_001364536|]
View 

Neprilysin [Caenorhabditis elegans]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
111-770 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 655.21  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 111 ANPCEDFYEFACGKYATRKVIAEHEKKVTVLSEMKKEMDRHLKDILEKTS-RENTTRSMKLAQIYFDSCMDEFSQDDLGV 189
Cdd:cd08662     1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAAsSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 190 QPLMSMISNLGGWPLLTnarfdsiDFQWEVLAGHLALYGVDGIFRVFVHSSFDDSDKNVLMFSPPKLFLEKKKFYREvPS 269
Cdd:cd08662    81 KPLKPLLDKIGGLPSLD-------DLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLD-EE 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 270 SNVYLQYYRQYILSLLSLLGVDMEDetgvIEYQVDDIIDFERRIANLTR-IELSRNHSSINNMITFGEFKRKYDKINWDA 348
Cdd:cd08662   153 NAEIREAYKKYIAKLLELLGADEEE----AEKLAEDVLAFETELAKISLsSEELRDPEKTYNPLTLAELQKLAPSIDWKA 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 349 FFNEemrgNLGRMPDSLVINVVDVNYFDNLYSLIKSKPLSSINNFLMWCLVSNYDMYLPAKYRKPMLDFRQKMYGVSSDD 428
Cdd:cd08662   229 YLKA----LGPPADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPE 304
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 429 PLWEVCVGEVRENLAMPLSTEYAQKFFTKKDKLVAEDMIRDLKKAMEQTLLNADWIDESTREAALMKLDAMGHKIGFPDS 508
Cdd:cd08662   305 PRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDK 384
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 509 LLNETAVLLPYAGVRLTANqYFDNAISLKKAAYRDALSKLHRTPSLIDWASPIIAVDAFHYFTGNEIIFPAGILQFPMFV 588
Cdd:cd08662   385 WRDYSALDIYYDDLNVSDS-YFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFD 463
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 589 PDAPAFSNYGAIGMGIGHEITHGYDDLGAQYDDKGNLRGWWHTETMTTFQKKKQCFVAQYgSKIEPQTGRKVDGKMTIGE 668
Cdd:cd08662   464 PDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQY-SNYEVPPGLHVNGKLTLGE 542
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 669 NIADNGGLRVAFQAYQLRSDREKETrrLPGLTDFSPNQLFFLAYANTWCEALKPSAIDHIMDTDVHSLGMFRVNVPLQNL 748
Cdd:cd08662   543 NIADNGGLRLAYRAYKKWLKENGPE--LPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNS 620
                         650       660
                  ....*....|....*....|..
gi 1799133714 749 PAFSKEFDCPIGSPMNPFEKCR 770
Cdd:cd08662   621 PEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
111-770 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 655.21  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 111 ANPCEDFYEFACGKYATRKVIAEHEKKVTVLSEMKKEMDRHLKDILEKTS-RENTTRSMKLAQIYFDSCMDEFSQDDLGV 189
Cdd:cd08662     1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAAsSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 190 QPLMSMISNLGGWPLLTnarfdsiDFQWEVLAGHLALYGVDGIFRVFVHSSFDDSDKNVLMFSPPKLFLEKKKFYREvPS 269
Cdd:cd08662    81 KPLKPLLDKIGGLPSLD-------DLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLD-EE 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 270 SNVYLQYYRQYILSLLSLLGVDMEDetgvIEYQVDDIIDFERRIANLTR-IELSRNHSSINNMITFGEFKRKYDKINWDA 348
Cdd:cd08662   153 NAEIREAYKKYIAKLLELLGADEEE----AEKLAEDVLAFETELAKISLsSEELRDPEKTYNPLTLAELQKLAPSIDWKA 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 349 FFNEemrgNLGRMPDSLVINVVDVNYFDNLYSLIKSKPLSSINNFLMWCLVSNYDMYLPAKYRKPMLDFRQKMYGVSSDD 428
Cdd:cd08662   229 YLKA----LGPPADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPE 304
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 429 PLWEVCVGEVRENLAMPLSTEYAQKFFTKKDKLVAEDMIRDLKKAMEQTLLNADWIDESTREAALMKLDAMGHKIGFPDS 508
Cdd:cd08662   305 PRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDK 384
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 509 LLNETAVLLPYAGVRLTANqYFDNAISLKKAAYRDALSKLHRTPSLIDWASPIIAVDAFHYFTGNEIIFPAGILQFPMFV 588
Cdd:cd08662   385 WRDYSALDIYYDDLNVSDS-YFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFD 463
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 589 PDAPAFSNYGAIGMGIGHEITHGYDDLGAQYDDKGNLRGWWHTETMTTFQKKKQCFVAQYgSKIEPQTGRKVDGKMTIGE 668
Cdd:cd08662   464 PDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQY-SNYEVPPGLHVNGKLTLGE 542
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 669 NIADNGGLRVAFQAYQLRSDREKETrrLPGLTDFSPNQLFFLAYANTWCEALKPSAIDHIMDTDVHSLGMFRVNVPLQNL 748
Cdd:cd08662   543 NIADNGGLRLAYRAYKKWLKENGPE--LPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNS 620
                         650       660
                  ....*....|....*....|..
gi 1799133714 749 PAFSKEFDCPIGSPMNPFEKCR 770
Cdd:cd08662   621 PEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
104-772 2.06e-154

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 465.01  E-value: 2.06e-154
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 104 LNNMNRDANPCEDFYEFACGKYATRKVIAEHEKKVTVLSEMKKEMDRHLKDILEKTSRENTTRSMKLAQI--YFDSCMDE 181
Cdd:COG3590    30 LANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAGSDEQKIgdLYASFMDE 109
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 182 FSQDDLGVQPLMsmisnlggwPLLtnARFDSI----DFQweVLAGHLALYGVDGIFRVFVHSSFDDSDKNVLMFSPPKLF 257
Cdd:COG3590   110 AAIEALGLAPLK---------PDL--ARIDAIkdkaDLA--ALLAALHRAGVGGLFGFGVDADLKNSTRYIAYLGQGGLG 176
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 258 LEKKKFYREVPSSNV-YLQYYRQYILSLLSLLGVDMEDETGvieyQVDDIIDFERRIAN--LTRIELsRNHSSINNMITF 334
Cdd:COG3590   177 LPDRDYYLKDDEKSAeIRAAYVAHVAKMLELAGYDEADAAA----AAEAVLALETALAKahWSRVEL-RDPEKTYNPMTV 251
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 335 GEFKRKYDKINWDAFFNEemrgnLGrMPDSLVINVVDVNYFDNLYSLIKSKPLSSINNFLMWCLVSNYDMYLPAKYRKPM 414
Cdd:COG3590   252 AELAKLAPGFDWDAYLKA-----LG-LPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKAFVDAN 325
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 415 LDFRQK-MYGVSSDDPLWEVCVGEVRENLAMPLSTEYAQKFFTKKDKLVAEDMIRDLKKAMEQTLLNADWIDESTREAAL 493
Cdd:COG3590   326 FDFYGKtLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDWMSPETKAKAL 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 494 MKLDAMGHKIGFPDSLLNetavllpYAGVRLTANQYFDNAISLKKAAYRDALSKLHR---------TPSLidwaspiiaV 564
Cdd:COG3590   406 EKLAAFTPKIGYPDKWRD-------YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKpvdrtewgmTPQT---------V 469
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 565 DAFHYFTGNEIIFPAGILQFPMFVPDAPAFSNYGAIGMGIGHEITHGYDDLGAQYDDKGNLRGWWHTETMTTFQKKKQCF 644
Cdd:COG3590   470 NAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKL 549
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 645 VAQYgSKIEPQTGRKVDGKMTIGENIADNGGLRVAFQAYQLrSDREKETRRLPGLTdfsPNQLFFLAYANTWCEALKPSA 724
Cdd:COG3590   550 VAQY-DAYEPLPGLHVNGKLTLGENIADLGGLSIAYDAYKL-SLKGKEAPVIDGFT---GDQRFFLGWAQVWRSKARDEA 624
                         650       660       670       680       690
                  ....*....|....*....|....*....|....*....|....*....|
gi 1799133714 725 IDHIMDTDVHSLGMFRVNVPLQNLPAFSKEFDCPIGSPM--NPFEKCRIW 772
Cdd:COG3590   625 LRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
113-506 8.82e-100

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 313.47  E-value: 8.82e-100
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 113 PCEDFYEFACGKYATRKVIAEHEKKVTVLSEMKKEMDRHLKDILEKT-SRENTTRSMKLAQIYFDSCMDEFSQDDLGVQP 191
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAaASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 192 LMSMISNLGGWPLLTNarfdsiDFQWEVLAGHLALYGVDGIFRVFVHSSFDDSDKNVLMFSPPKLFLEKKKFY--REVPS 269
Cdd:pfam05649  81 LKPLLDEIGGPLANKD------KFDLLETLAKLRRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYlkDRDEK 154
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 270 SNVYLQYYRQYILSLLSLLGVDMEDETgvieyQVDDIIDFERRIANLTR-IELSRNHSSINNMITFGEFKRKYDKINWDA 348
Cdd:pfam05649 155 SAEIREAYKAYIAKLLTLLGASEEAAA-----LAEEVLAFETKLAKASLsREERRDPEKTYNPMTLAELQKLAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 349 FFNEEMrgnLGRMPDSLVInVVDVNYFDNLYSLIKSKPLSSINNFLMWCLVSNYDMYLPAKYRKPMLDFRQKMYGVSSDd 428
Cdd:pfam05649 230 YLNAAG---LPDVPSDEVI-VSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSGTKQR- 304
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1799133714 429 PLWEVCVGEVRENLAMPLSTEYAQKFFTKKDKLVAEDMIRDLKKAMEQTLLNADWIDESTREAALMKLDAMGHKIGFP 506
Cdd:pfam05649 305 PRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
111-770 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 655.21  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 111 ANPCEDFYEFACGKYATRKVIAEHEKKVTVLSEMKKEMDRHLKDILEKTS-RENTTRSMKLAQIYFDSCMDEFSQDDLGV 189
Cdd:cd08662     1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAAsSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 190 QPLMSMISNLGGWPLLTnarfdsiDFQWEVLAGHLALYGVDGIFRVFVHSSFDDSDKNVLMFSPPKLFLEKKKFYREvPS 269
Cdd:cd08662    81 KPLKPLLDKIGGLPSLD-------DLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLD-EE 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 270 SNVYLQYYRQYILSLLSLLGVDMEDetgvIEYQVDDIIDFERRIANLTR-IELSRNHSSINNMITFGEFKRKYDKINWDA 348
Cdd:cd08662   153 NAEIREAYKKYIAKLLELLGADEEE----AEKLAEDVLAFETELAKISLsSEELRDPEKTYNPLTLAELQKLAPSIDWKA 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 349 FFNEemrgNLGRMPDSLVINVVDVNYFDNLYSLIKSKPLSSINNFLMWCLVSNYDMYLPAKYRKPMLDFRQKMYGVSSDD 428
Cdd:cd08662   229 YLKA----LGPPADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPE 304
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 429 PLWEVCVGEVRENLAMPLSTEYAQKFFTKKDKLVAEDMIRDLKKAMEQTLLNADWIDESTREAALMKLDAMGHKIGFPDS 508
Cdd:cd08662   305 PRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDK 384
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 509 LLNETAVLLPYAGVRLTANqYFDNAISLKKAAYRDALSKLHRTPSLIDWASPIIAVDAFHYFTGNEIIFPAGILQFPMFV 588
Cdd:cd08662   385 WRDYSALDIYYDDLNVSDS-YFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFD 463
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 589 PDAPAFSNYGAIGMGIGHEITHGYDDLGAQYDDKGNLRGWWHTETMTTFQKKKQCFVAQYgSKIEPQTGRKVDGKMTIGE 668
Cdd:cd08662   464 PDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQY-SNYEVPPGLHVNGKLTLGE 542
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 669 NIADNGGLRVAFQAYQLRSDREKETrrLPGLTDFSPNQLFFLAYANTWCEALKPSAIDHIMDTDVHSLGMFRVNVPLQNL 748
Cdd:cd08662   543 NIADNGGLRLAYRAYKKWLKENGPE--LPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSNS 620
                         650       660
                  ....*....|....*....|..
gi 1799133714 749 PAFSKEFDCPIGSPMNPFEKCR 770
Cdd:cd08662   621 PEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
104-772 2.06e-154

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 465.01  E-value: 2.06e-154
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 104 LNNMNRDANPCEDFYEFACGKYATRKVIAEHEKKVTVLSEMKKEMDRHLKDILEKTSRENTTRSMKLAQI--YFDSCMDE 181
Cdd:COG3590    30 LANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAGSDEQKIgdLYASFMDE 109
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 182 FSQDDLGVQPLMsmisnlggwPLLtnARFDSI----DFQweVLAGHLALYGVDGIFRVFVHSSFDDSDKNVLMFSPPKLF 257
Cdd:COG3590   110 AAIEALGLAPLK---------PDL--ARIDAIkdkaDLA--ALLAALHRAGVGGLFGFGVDADLKNSTRYIAYLGQGGLG 176
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 258 LEKKKFYREVPSSNV-YLQYYRQYILSLLSLLGVDMEDETGvieyQVDDIIDFERRIAN--LTRIELsRNHSSINNMITF 334
Cdd:COG3590   177 LPDRDYYLKDDEKSAeIRAAYVAHVAKMLELAGYDEADAAA----AAEAVLALETALAKahWSRVEL-RDPEKTYNPMTV 251
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 335 GEFKRKYDKINWDAFFNEemrgnLGrMPDSLVINVVDVNYFDNLYSLIKSKPLSSINNFLMWCLVSNYDMYLPAKYRKPM 414
Cdd:COG3590   252 AELAKLAPGFDWDAYLKA-----LG-LPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKAFVDAN 325
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 415 LDFRQK-MYGVSSDDPLWEVCVGEVRENLAMPLSTEYAQKFFTKKDKLVAEDMIRDLKKAMEQTLLNADWIDESTREAAL 493
Cdd:COG3590   326 FDFYGKtLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDWMSPETKAKAL 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 494 MKLDAMGHKIGFPDSLLNetavllpYAGVRLTANQYFDNAISLKKAAYRDALSKLHR---------TPSLidwaspiiaV 564
Cdd:COG3590   406 EKLAAFTPKIGYPDKWRD-------YSGLEIKRDDLVGNVLRASAFEYQRELAKLGKpvdrtewgmTPQT---------V 469
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 565 DAFHYFTGNEIIFPAGILQFPMFVPDAPAFSNYGAIGMGIGHEITHGYDDLGAQYDDKGNLRGWWHTETMTTFQKKKQCF 644
Cdd:COG3590   470 NAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKL 549
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 645 VAQYgSKIEPQTGRKVDGKMTIGENIADNGGLRVAFQAYQLrSDREKETRRLPGLTdfsPNQLFFLAYANTWCEALKPSA 724
Cdd:COG3590   550 VAQY-DAYEPLPGLHVNGKLTLGENIADLGGLSIAYDAYKL-SLKGKEAPVIDGFT---GDQRFFLGWAQVWRSKARDEA 624
                         650       660       670       680       690
                  ....*....|....*....|....*....|....*....|....*....|
gi 1799133714 725 IDHIMDTDVHSLGMFRVNVPLQNLPAFSKEFDCPIGSPM--NPFEKCRIW 772
Cdd:COG3590   625 LRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
113-506 8.82e-100

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 313.47  E-value: 8.82e-100
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 113 PCEDFYEFACGKYATRKVIAEHEKKVTVLSEMKKEMDRHLKDILEKT-SRENTTRSMKLAQIYFDSCMDEFSQDDLGVQP 191
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAaASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 192 LMSMISNLGGWPLLTNarfdsiDFQWEVLAGHLALYGVDGIFRVFVHSSFDDSDKNVLMFSPPKLFLEKKKFY--REVPS 269
Cdd:pfam05649  81 LKPLLDEIGGPLANKD------KFDLLETLAKLRRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYlkDRDEK 154
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 270 SNVYLQYYRQYILSLLSLLGVDMEDETgvieyQVDDIIDFERRIANLTR-IELSRNHSSINNMITFGEFKRKYDKINWDA 348
Cdd:pfam05649 155 SAEIREAYKAYIAKLLTLLGASEEAAA-----LAEEVLAFETKLAKASLsREERRDPEKTYNPMTLAELQKLAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 349 FFNEEMrgnLGRMPDSLVInVVDVNYFDNLYSLIKSKPLSSINNFLMWCLVSNYDMYLPAKYRKPMLDFRQKMYGVSSDd 428
Cdd:pfam05649 230 YLNAAG---LPDVPSDEVI-VSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSGTKQR- 304
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1799133714 429 PLWEVCVGEVRENLAMPLSTEYAQKFFTKKDKLVAEDMIRDLKKAMEQTLLNADWIDESTREAALMKLDAMGHKIGFP 506
Cdd:pfam05649 305 PRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
566-771 9.71e-76

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 243.86  E-value: 9.71e-76
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 566 AFHYFTGNEIIFPAGILQFPMFVPDAPAFSNYGAIGMGIGHEITHGYDDLGAQYDDKGNLRGWWHTETMTTFQKKKQCFV 645
Cdd:pfam01431   2 AYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCLI 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133714 646 AQYGSKIEPQTGRKVDGKMTIGENIADNGGLRVAFQAYQLRSDREKEtrRLPGLTDFSPNQLFFLAYANTWCEALKPSAI 725
Cdd:pfam01431  82 EQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANET--VLPGFENLTPDQLFFRGAAQIWCMKQSPAEV 159
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*.
gi 1799133714 726 DHIMDTDVHSLGMFRVNVPLQNLPAFSKEFDCPIGSPMNPFEKCRI 771
Cdd:pfam01431 160 LRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH